Syamdas Bandyopadhyay
Overview
Explore the profile of Syamdas Bandyopadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bammigatti A, Ghosh S, Bandyopadhyay S, Saha B
Cytokine
. 2024 Nov;
185:156824.
PMID: 39615244
CD40-CD40-ligand (CD40L) interaction plays crucial immunoregulatory roles, as CD40 signals through different signaling intermediates to convert the messages from CD40L to effector functions. Being a TNFα receptor family member, CD40...
2.
Bandyopadhyay S, Gurjar D, Saha B, Bodhale N
Hum Immunol
. 2023 Aug;
84(11):590-599.
PMID: 37596136
Previously, we established that as a function of its mode of interaction with its ligand or cellular conditions such as membrane lipids, preexisting signaling intermediates activation status, a transmembrane receptor,...
3.
Jawed J, Banerjee S, Bandyopadhyay S, Parveen S, Chowdhury B, Saini P, et al.
Biomed Pharmacother
. 2018 Jul;
106:724-732.
PMID: 29990864
NOD like receptors (NLR) are essential pathogen associated molecular pattern receptors of cytoplasmic origin. During several intracellular parasitic infections NLR played vital role for host protective immune response against the...
4.
Jawed J, Majumder S, Bandyopadhyay S, Biswas S, Parveen S, Majumdar S
Pathog Dis
. 2016 May;
74(5).
PMID: 27150838
Emergence of drug resistance during visceral leishmaniasis (VL) is a major obstacle imposed during successful therapy. An effective vaccine strategy against this disease is therefore necessary. Our present study exploited...
5.
Bandyopadhyay S, Mahapatra S, Chowdhury B, Jha M, Das S, Halder K, et al.
PLoS One
. 2015 Nov;
10(11):e0142800.
PMID: 26559815
Leishmania donovani, a protozoan parasite, causes the disease visceral leishmanisis (VL), characterized by inappropriate CD8+ T-cell activation. Therefore, we examined whether the Toll-like Receptor 2 (TLR2) ligand Ara-LAM, a cell...
6.
Bandyopadhyay S, Chandel H, Singh S, Roy S, Krishnasastry M, Saha B
Hum Immunol
. 2015 Oct;
76(9):673-80.
PMID: 26429321
CD40, as a single receptor that binds CD154 (CD40-ligand or CD40L), regulates counteractive effector functions such as production of pro- and anti-inflammatory cytokines. Therefore, we examined whether such dual messages...
7.
Bandyopadhyay S, Bhattacharjee A, Banerjee S, Halder K, Das S, Chowdhury B, et al.
Infect Immun
. 2015 Sep;
83(12):4476-86.
PMID: 26351281
CD11b(+) Gr1(+) myeloid-derived suppressor cells (MDSCs), a heterogeneous population of precursor cells, modulate protective immunity against visceral leishmaniasis by suppressing T cell functions. We observed that CD11b(+) Gr1(+) MDSCs, which...
8.
Chowdhury B, Das S, Majumder S, Halder K, Ghosh S, Biswas S, et al.
Pathog Dis
. 2015 Aug;
73(8):ftv063.
PMID: 26297915
Visceral leishmaniasis (VL), caused by a protozoan parasite Leishmania donovani, is still a threat to mankind due to treatment failure, drug resistance and coinfection with HIV. The limitations of first-line...
9.
Chowdhury B, Bandyopadhyay S, Das S, Majumder S, Jha M, Bhattacharyya Majumdar S, et al.
PLoS One
. 2015 Feb;
10(2):e0117247.
PMID: 25658110
Visceral leishmaniasis (VL), which is endemic as a major infectious disease in the tropical and subtropical countries, is caused by a protozoan parasite Leishmania donovani. At present, restricted treatment options...
10.
Khan S, Alonso-Sarduy L, Alonso L, Roduit C, Bandyopadhyay S, Singh S, et al.
Hum Immunol
. 2012 Mar;
73(5):465-9.
PMID: 22406255
The antigen-presenting cell–expressed CD40 is implied in the regulation of counteractive immune responses such as induction of pro-inflammatory and anti-inflammatory cytokines interleukin (IL)–12 and IL-10, respectively. The mechanism of this...